Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Won Jin Ho(Johns Hopkins University), Qingfeng Zhu(Johns Hopkins University), Jennifer N. Durham(Johns Hopkins University), Aleksandra Popović(Johns Hopkins University), Stephanie Xavier(Johns Hopkins University), James M. Leatherman(Johns Hopkins University), Aditya Mohan(Johns Hopkins University), Guanglan Mo(Johns Hopkins University), Shu Zhang(Johns Hopkins University), Nicole Groß(Johns Hopkins University), Soren Charmsaz(Johns Hopkins University), Dongxia Lin(Fluidigm (United States)), Derek Quong(Fluidigm (United States)), Brad Wilt(Johns Hopkins University), Ihab R. Kamel(Johns Hopkins University), Matthew J. Weiss(Johns Hopkins University), Benjamin Philosophe(Johns Hopkins University), Richard A. Burkhart(Johns Hopkins University), William R. Burns(Johns Hopkins University), Chris Shubert(Johns Hopkins University), Aslam Ejaz(Johns Hopkins University), Jin He(Johns Hopkins University), Atul Deshpande(Johns Hopkins University), Ludmila Danilova(Johns Hopkins University), Genevieve Stein-O’Brien(Johns Hopkins University), Elizabeth A. Sugar(Johns Hopkins University), Daniel A. Laheru(Johns Hopkins University), Robert A. Anders(Johns Hopkins University), Elana J. Fertig(Johns Hopkins University), Elizabeth M. Jaffee(Johns Hopkins University), Mark Yarchoan(Johns Hopkins University)
Cited by 344Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis